Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
The present invention relates to a pharmaceutical delivery device for application of a pharmaceutical to mucosal surfaces. The device comprises an adhesive layer and a non-adhesive backing layer, and the pharmaceutical may be provided in either or both layers. Upon application, the device adheres to the mucosal surface, providing localized drug delivery and protection to the treatment site. The kinetics of erodability are easily adjusted by varying the number of layers and/or the components.
1 - 33 . (Cancelled).
34 . A pharmaceutical carrier device comprising a layered film having a first water-erodible adhesive layer to be placed in contact with a mucosal surface, a second water-erodible non-adhesive backing layer, and a third water-erodible adhesive layer between said first adhesive layer and said second backing layer, wherein said third layer comprises at least one component that acts to adjust the kinetics of the erodibility of the device, and wherein a pharmaceutical may be incorporated into said first layer, said second layer, or both layers.
35 . The pharmaceutical device of claim 34 , which delivers a pharmaceutical locally in a unidirectional manner when applied to a mucosal surface.
36 . The pharmaceutical device of claim 34 , wherein one or both of the first and second layers comprise at least one component that acts to adjust the kinetics of the erodibility of the layer.
37 . The pharmaceutical device of claim 34 , wherein said component that acts to adjust the kinetics of the erodibility of the device is a water-based emulsion of polylactide, polyglycolide, lactide-glycolide copolymers, poly-ε-caprolactone and derivatives, polyorthoesters and derivatives, polyanhydrides and derivatives, methyl cellulose, ethyl cellulose, vinyl acetate, cellulose acetate, silicone, or polyisobutylene and derivatives, alone or in combination.
38 . The pharmaceutical device of claim 34 , wherein said component that acts to adjust the kinetics of the erodibility of the device is an alkyl glycol, propylene glycol, polyethyleneglycol, or oleate, sebacate, stearate, or phthalate esters of glycerol, alone or in combination.
39 . The pharmaceutical device of claim 34 , wherein said first water-erodable adhesive layer comprises at least one film-forming water-erodable polymer and at least one bioadhesive polymer.
40 . The pharmaceutical device of claim 39 , wherein said film forming water-erodable polymer is selected from the group consisting of hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, hydroxyethyl methyl cellulose, polyvinyl alcohol, polyethylene glycol, polyethylene oxide, ethylene oxide-propylene oxide co-polymers, collagen, gelatin, albumin, polyaminoacids, polyphosphazenes, polysaccharides, chitin, and chitosan, alone or in combination.
41 . The pharmaceutical device of claim 39 , wherein said bioadhesive polymer is selected from the group consisting of polyacrylic acid, polyvinyl pyrrolidone, and sodium carboxymethyl cellulose, alone or in combination.
42 . The pharmaceutical device of claim 34 , wherein said second water-erodible non-adhesive backing layer comprises at least one film-forming water-erodable polymer.
43 . The pharmaceutical device of claim 42 , wherein said film forming water-erodable polymer is selected from the group consisting of hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, hydroxyethyl methyl cellulose, polyvinyl alcohol, polyethylene glycol, polyethylene oxide, ethylene oxide-propylene oxide co-polymers, collagen, gelatin, albumin, polyaminoacids, polyphosphazenes, polysaccharides, chitin, and chitosan, alone or in combination.
44 . The pharmaceutical device of claim 34 , wherein said first water-erodable adhesive layer is has a surface area smaller than the other layers.
45 . The pharmaceutical device of claim 44 , wherein said third adhesive layer has a surface area that is larger than and that is sufficient to encompass said first water-erodable adhesive layer and to contact the mucosal surface.
46 . The pharmaceutical device of claim 44 , wherein said first water-erodable adhesive layer has a surface area between about 5% and about 50% smaller than the other layers.
47 . The pharmaceutical device of claim 44 , wherein said first water-erodable adhesive layer has a surface area between about 10% and about 30% smaller than the other layers.
48 . The pharmaceutical device of claim 35 , wherein a pharmaceutical present in the backing layer is prevented from entering the mucosal layer to which the device is adhered.
49 . The pharmaceutical device of claim 35 , wherein pharmaceuticals present in the backing layer and the first adhesive layer are prevented from mixing.
50 . The pharmaceutical device of claim 34 , wherein said pharmaceutical incorporated within said first layer, said second layer, or both layers comprises an anti-inflammatory analgesic agent, a steroidal anti-inflammatory agent, an antihistamine, a local anesthetic, a bactericide, a disinfectant, a vasoconstrictor, a hemostatic, a chemotherapeutic drug, an antibiotic, a keratolytic, a cauterizing agent, an antiviral, an antirheumatic, an antihypertensive, a bronchodilator, an anticholinergic, an antiemetic, a hormone, a macromolecule, a peptide, a protein, or a vaccine, alone or in combination.
51 . The pharmaceutical device of claim 34 , wherein the thickness of each layer may vary from 10% to 90% of the overall thickness of the layered device.
52 . The pharmaceutical device of claim 51 , wherein the thickness of each layer may vary from 0.01 mm to 0.9 mm.
53 . The pharmaceutical device of claim 51 , wherein the thickness of each layer may vary from 0.03 mm to 0.6 mm.